https://www.linkedin.com/posts/rentschler-biopharma_strategic-collaboration-with-coriolis-pharma-activity-7401548202929254400-Gbr4?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAAGBIr0BAP_3y98KQZnfRhIRQ-kqOWXe0fc

We are happy to announce that we have entered a strategic collaboration with Coriolis Pharma, a leader in formulation research and development for biopharmaceuticals, to deliver integrated biopharma solutions for our clients. 
Starting today, we will be combining our companies’ complementary scientific and technical expertise, and offer seamless, end-to-end solutions – from early formulation development through to commercial manufacturing. 
 
Our clients will benefit from 
▫️ Complementary expertise and accelerated timelines 
▫️ Reduced complexity and risk in development and manufacturing 
▫️ A unified interface and aligned project teams 
 
Benedikt von Braunmühl, our Chief Executive Officer, said: “This marks an important step for both our organizations and for our global clients, and their patients. Coriolis Pharma shares our focus on technical excellence, reliability, as well as our client-centric approach. By bringing together our individual areas of excellence, bioprocess development and manufacturing on our side, and scientific and analytical expertise in formulation development at Coriolis, we look forward to addressing complex challenges across the biopharmaceutical value chain more efficiently and faster. This collaboration perfectly exemplifies our vision of advancing medicine to save lives. Together.” 
 
Read our full press release here: https://lnkd.in/e8sHGsW5 
 
hashtag#RentschlerBiopharma hashtag#CDMO hashtag#ReliabitliyYouCanTrust hashtag#CoriolisPharma hashtag#FormulationDevelopment

See all Member News